Contact: Peter Patterson
(202) 835-8718
800-892-1400 ext. 1718
Email: ppatterson@aacc.org

Thursday, April 14, 2011
AACC Announces Webinar 'Antiphospholipid Syndrome - Issues And Answers'

Washington, DC, April 14, 2011         The American Association for Clinical Chemistry (AACC) announces a webinar Antiphospholipid Syndrome: Issues and Answers being held on Wednesday, May 11, 2011 at 2:00pm Eastern.  The webinar will last 90 minutes.

Antiphospholipid syndrome (APS) is an autoimmune disorder in which autoantibodies are directed against phospholipid–protein complexes. APS causes blood clots to form in the legs, lungs, brain as well as the placenta of pregnant women resulting in miscarriages. As these clinical features of the disease are relatively common in the general population, the need for a correct diagnosis of APS is critical.  APS and systemic lupus erythematosus (SLE) share both clinical and biological manifestations, further complicating diagnosis. Despite recent advances, diagnosis of APS remains a challenge. APS patients can present with a wide range of clinical symptoms and clinical laboratory tests have limitations. Current testing strategies rely on lupus anticoagulant, anticardiolipin and anti-B2 glycoprotein. However the diagnostic value of a positive result in only one assay is controversial. Due to the unique challenges of antiphospholipid testing and interpretation of results, clinical labs are increasingly bringing this technology in house so that they can better support their clinical staff and improve patient care.

The expert panel for the webinar is Gyorgy Abel, MD, Director, Clinical Immunology and Molecular Diagnostics at the Lahey Clinic in Burlington, MA, Robert A. Roubey, MD, Associate Professor of Medicine, Division of Rheumatology, Allergy, and Immunology at the Thurston Arthritis Research Center of The University of North Carolina in, Chapel Hill, NC, and Melissa R. Snyder, PhD, Laboratory Director, Department of Laboratory Medicine and Pathology at the Mayo Foundation in Rochester, MN. The panel will review the prevalence, clinical manifestations, and classification criteria of APS, the syndrome, serologic and functional tests available for the evaluation of APS, current efforts being made regarding standardization of antiphospholipid antibody testing and more.

This program is made possible in part by a generous educational grant from Bio-Rad.

AACC invites interested journalists to attend the webinar at no cost. For a complimentary registration, complete and submit a Press Registration Form. For more information about the event or AACC, contact Peter Patterson on either of the above phone numbers or at ppatterson@aacc.org.

# # # # #

AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations. AACC brings this community together with programs that advance knowledge, expertise, and innovation.